Sarah Robertson, NP
Family · Palmdale, CANPI 1356690234
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 262 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 56 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,457 and has fallen 54.2% since, to $668 in 2025. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 262 payments — averaging $21.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$627
- Merck$507
- Corcept Therapeutics$489
- AbbVie$377
- Amgen$324
- Dexcom, Inc.$241
- plus $3K from 50 others
What the payments were for
- Food & beverage$5,578100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,578 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 11 | $1,502 |
| Levothyroxine Sodium | 47 | $859 |
| Rosuvastatin Calcium | 34 | $504 |
| Amlodipine Besylate | 56 | $503 |
| Ezetimibe | 13 | $488 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $437 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 30 | $374 |
| Atorvastatin Calcium | 54 | $334 |
| Losartan Potassium | 21 | $313 |
| Gabapentin | 18 | $278 |
| Metformin Hcl | 16 | $268 |
| Simvastatin | 19 | $250 |
| Lisinopril | 30 | $236 |
| Sertraline Hcl | 15 | $185 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $179 |
Paid to pharmacies, not to this prescriber.
Other family in Palmdale
- So-Young KimPalmdale$98K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.